These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33083949)

  • 1. Frequency and spectrum of mutations across 94 cancer predisposition genes in African American women with invasive breast cancer.
    Lovejoy LA; Rummel SK; Turner CE; Shriver CD; Ellsworth RE
    Fam Cancer; 2021 Jul; 20(3):181-187. PubMed ID: 33083949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.
    Yadav S; Hu C; Hart SN; Boddicker N; Polley EC; Na J; Gnanaolivu R; Lee KY; Lindstrom T; Armasu S; Fitz-Gibbon P; Ghosh K; Stan DL; Pruthi S; Neal L; Sandhu N; Rhodes DJ; Klassen C; Peethambaram PP; Haddad TC; Olson JE; Hoskin TL; Goetz MP; Domchek SM; Boughey JC; Ruddy KJ; Couch FJ
    J Clin Oncol; 2020 May; 38(13):1409-1418. PubMed ID: 32125938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations.
    Ademuyiwa FO; Salyer P; Ma Y; Fisher S; Colditz G; Weilbaecher K; Bierut LJ
    Breast Cancer Res Treat; 2019 Nov; 178(1):151-159. PubMed ID: 31325073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
    Nanda R; Schumm LP; Cummings S; Fackenthal JD; Sveen L; Ademuyiwa F; Cobleigh M; Esserman L; Lindor NM; Neuhausen SL; Olopade OI
    JAMA; 2005 Oct; 294(15):1925-33. PubMed ID: 16234499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-gene panel study in hereditary breast and ovarian cancer in Colombia.
    Cock-Rada AM; Ossa CA; Garcia HI; Gomez LR
    Fam Cancer; 2018 Jan; 17(1):23-30. PubMed ID: 28528518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies.
    Pal T; Vadaparampil S; Betts J; Miree C; Li S; Narod SA
    Genet Test; 2008 Sep; 12(3):401-7. PubMed ID: 18752448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women.
    Haffty BG; Silber A; Matloff E; Chung J; Lannin D
    J Med Genet; 2006 Feb; 43(2):133-7. PubMed ID: 15983021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel germline PALB2 truncating mutations in African American breast cancer patients.
    Zheng Y; Zhang J; Niu Q; Huo D; Olopade OI
    Cancer; 2012 Mar; 118(5):1362-70. PubMed ID: 21932393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia.
    Yang XR; Devi BCR; Sung H; Guida J; Mucaki EJ; Xiao Y; Best A; Garland L; Xie Y; Hu N; Rodriguez-Herrera M; Wang C; Jones K; Luo W; Hicks B; Tang TS; Moitra K; Rogan PK; Dean M
    Breast Cancer Res Treat; 2017 Oct; 165(3):687-697. PubMed ID: 28664506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
    Ricks-Santi L; McDonald JT; Gold B; Dean M; Thompson N; Abbas M; Wilson B; Kanaan Y; Naab TJ; Dunston G
    Ethn Dis; 2017; 27(2):169-178. PubMed ID: 28439188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
    Buys SS; Sandbach JF; Gammon A; Patel G; Kidd J; Brown KL; Sharma L; Saam J; Lancaster J; Daly MB
    Cancer; 2017 May; 123(10):1721-1730. PubMed ID: 28085182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 and BRCA2 mutations in a study of African American breast cancer patients.
    Pal T; Permuth-Wey J; Holtje T; Sutphen R
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1794-9. PubMed ID: 15533909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.
    Palmer JR; Polley EC; Hu C; John EM; Haiman C; Hart SN; Gaudet M; Pal T; Anton-Culver H; Trentham-Dietz A; Bernstein L; Ambrosone CB; Bandera EV; Bertrand KA; Bethea TN; Gao C; Gnanaolivu RD; Huang H; Lee KY; LeMarchand L; Na J; Sandler DP; Shah PD; Yadav S; Yang W; Weitzel JN; Domchek SM; Goldgar DE; Nathanson KL; Kraft P; Yao S; Couch FJ
    J Natl Cancer Inst; 2020 Dec; 112(12):1213-1221. PubMed ID: 32427313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing.
    Shimelis H; LaDuca H; Hu C; Hart SN; Na J; Thomas A; Akinhanmi M; Moore RM; Brauch H; Cox A; Eccles DM; Ewart-Toland A; Fasching PA; Fostira F; Garber J; Godwin AK; Konstantopoulou I; Nevanlinna H; Sharma P; Yannoukakos D; Yao S; Feng BJ; Tippin Davis B; Lilyquist J; Pesaran T; Goldgar DE; Polley EC; Dolinsky JS; Couch FJ
    J Natl Cancer Inst; 2018 Aug; 110(8):855-862. PubMed ID: 30099541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline mutations of multiple breast cancer-related genes are differentially associated with triple-negative breast cancers and prognostic factors.
    Hata C; Nakaoka H; Xiang Y; Wang D; Yang A; Liu D; Liu F; Zou Q; Wei L; Zheng K; Inoue I; You H
    J Hum Genet; 2020 Jul; 65(7):577-587. PubMed ID: 32029870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population.
    Wong ES; Shekar S; Chan CH; Hong LZ; Poon SY; Silla T; Lin C; Kumar V; Davila S; Voorhoeve M; Thike AA; Ho GH; Yap YS; Tan PH; Tan MH; Ang P; Lee AS
    PLoS One; 2015; 10(7):e0134408. PubMed ID: 26221963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary variants of unknown significance in African American women with breast cancer.
    McDonald JT; Ricks-Santi LJ
    PLoS One; 2022; 17(10):e0273835. PubMed ID: 36315513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited predisposition to breast cancer among African American women.
    Churpek JE; Walsh T; Zheng Y; Moton Z; Thornton AM; Lee MK; Casadei S; Watts A; Neistadt B; Churpek MM; Huo D; Zvosec C; Liu F; Niu Q; Marquez R; Zhang J; Fackenthal J; King MC; Olopade OI
    Breast Cancer Res Treat; 2015 Jan; 149(1):31-9. PubMed ID: 25428789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancer.
    Kessler L; Domchek S; Stopfer J; Halbert CH
    Community Genet; 2008; 11(4):193-200. PubMed ID: 18417966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.